The secretion of GLP-1 is usually considered to be inhibited in T2D; however, medications such as metformin have been shown to have a direct and AMP-activated protein kinase (AMPK)-dependent effect on GLP-1-secreting L-cells of the gastrointestinal tract (38). This evidence concerns the gene GCG and type 2 diabetes mellitus.